Coya Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Coya Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $15.21. The average 1-year stock price forecast is 244.12% higher than the current stock price, while the lowest is $12 (+171.49%) and the highest is $18 (+307.24%).

Price Target: $15.21 (+244.12%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$15.21	$15.5	$18
Change	+171.49%	+244.12%	+250.68%	+307.24%

Analyst Ratings

The average analyst rating for Coya Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	7	5	6
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Boobalan Pachaiyappan Roth MKM	Roth MKM	Buy Initiates $12	Buy	Initiates	$12	+171.49%	Jun 5, 2026
Chad Messer Lake Street	Lake Street	Buy Maintains $17	Buy	Maintains	$17	+284.62%	May 22, 2026
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $18	Buy	Reiterates	$18	+307.24%	May 13, 2026
Keay Nakae Chardan Capital	Chardan Capital	Buy Maintains $14	Buy	Maintains	$14	+216.74%	May 13, 2026
Thomas Shrader BTIG	BTIG	Buy Maintains $16	Buy	Maintains	$16	+261.99%	Mar 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.35M

from 7.95M

-70.45%

from 7.95M

Revenue Next Year

5.73M

from 2.35M

144.24%

from 2.35M

EPS This Year

-1.48

from -1.27

EPS Next Year

-1.73

from -1.48

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	6.00M	3.55M	7.95M	2.35M
Revenue Growth	-	-	-	-40.79%	123.57%	-70.45%
Gross Profit	-	-4.41M	500.68K	-8.31M	-8.79M	2.35M
Gross Margin	-	-	8.34%	-233.86%	-110.61%	100.00%
Operating Income	-4.87M	-9.29M	-7.36M	-17.22M	-20.27M	-32.42M
Net Income	-4.89M	-12.24M	-7.99M	-14.88M	-21.23M	-30.98M
EPS	-	-	-	-	-1.27	-1.48
Free Cash Flow	-2.45M	-3.43M	-10.33M	-6.73M	-4.61M	-40.00M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	10.3M
Avg	2.3M
Low	251,000

Revenue Growth

Revenue Growth	2026	2027	2028
High	29.0%
Avg	-70.5%
Low	-96.8%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.48
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-